Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Qinglei Hang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0419-6621; OpenAlex author ID A5055521602. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers

Papers 4

  1. Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance. Last author DOI 10.3390/cancers14092115↗
  2. Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications. Last author DOI 10.3390/cancers14143377↗
  3. Prognostic, Diagnostic, and Clinicopathological Significance of Circular RNAs in Pancreatic Cancer: A Systematic Review and Meta-Analysis. Last author DOI 10.3390/cancers14246187↗
  4. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Co-author DOI 10.1038/s41467-021-27349-7↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiajia Li · 3 shared papers, 2022 · strength 0.55
  2. Di Zhao · 1 shared paper, 2021 · strength 0.10
  3. Yalan Deng · 1 shared paper, 2021 · strength 0.10
  4. Wenjuan Yin · 1 shared paper, 2021 · strength 0.10
  5. Jun Yao · 1 shared paper, 2021 · strength 0.10
  6. Haoqiang Ying · 1 shared paper, 2021 · strength 0.10
  7. Li Ma · 1 shared paper, 2021 · strength 0.10
  8. Mien‐Chie Hung · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.